Medtronic plc MDT.BA Stock
Medtronic plc Price Chart
Medtronic plc MDT.BA Financial and Trading Overview
Medtronic plc stock price | 21000 ARS |
Previous Close | 11023.5 ARS |
Open | 11073.5 ARS |
Bid | 11045 ARS x N/A |
Ask | 11240 ARS x N/A |
Day's Range | 11058.5 - 11147 ARS |
52 Week Range | 75.7 - 11147 ARS |
Volume | 327 ARS |
Avg. Volume | 0 ARS |
Market Cap | 25.54T ARS |
Beta (5Y Monthly) | 0.721478 |
PE Ratio (TTM) | 903.28735 |
EPS (TTM) | 5453.7 ARS |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | June 22, 2023 |
1y Target Est | N/A |
MDT.BA Valuation Measures
Enterprise Value | 29.36T ARS |
Trailing P/E | 903.28735 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 817.85754 |
Price/Book (mrq) | 575.33923 |
Enterprise Value/Revenue | 940.114 |
Enterprise Value/EBITDA | 3205.955 |
Trading Information
Medtronic plc Stock Price History
Beta (5Y Monthly) | 0.721478 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11147 ARS |
52 Week Low | 75.7 ARS |
50-Day Moving Average | 75.7 ARS |
200-Day Moving Average | 75.7 ARS |
MDT.BA Share Statistics
Avg. Volume (3 month) | 0 ARS |
Avg. Daily Volume (10-Days) | 0 ARS |
Shares Outstanding | 665.4M |
Float | 2.66B |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.73 |
Trailing Annual Dividend Yield | 0.024% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0625 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | April 28, 2023 |
Most Recent Quarter (mrq) | April 28, 2023 |
Next Fiscal Year End | April 28, 2024 |
Profitability
Profit Margin | 12.03% |
Operating Margin (ttm) | 20.68% |
Gross Margin | 66.19% |
EBITDA Margin | 29.32% |
Management Effectiveness
Return on Assets (ttm) | 4.43% |
Return on Equity (ttm) | 7.24% |
Income Statement
Revenue (ttm) | 31.23B ARS |
Revenue Per Share (ttm) | 11.74 ARS |
Quarterly Revenue Growth (yoy) | 5.60% |
Gross Profit (ttm) | N/A |
EBITDA | 9.16B ARS |
Net Income Avi to Common (ttm) | 3.76B ARS |
Diluted EPS (ttm) | 12.32 |
Quarterly Earnings Growth (yoy) | -20.59% |
Balance Sheet
Total Cash (mrq) | 7.96B ARS |
Total Cash Per Share (mrq) | 2.99 ARS |
Total Debt (mrq) | 24.36B ARS |
Total Debt/Equity (mrq) | 47.16 ARS |
Current Ratio (mrq) | 2.395 |
Book Value Per Share (mrq) | 19.3425 |
Cash Flow Statement
Operating Cash Flow (ttm) | 6.04B ARS |
Levered Free Cash Flow (ttm) | 4.55B ARS |
Profile of Medtronic plc
Country | Argentina |
State | N/A |
City | Dublin |
Address | 20 On Hatch |
ZIP | 2 |
Phone | 353 1 438 1700 |
Website | https://www.medtronic.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 95000 |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Q&A For Medtronic plc Stock
What is a current MDT.BA stock price?
Medtronic plc MDT.BA stock price today per share is 21000 ARS.
How to purchase Medtronic plc stock?
You can buy MDT.BA shares on the Buenos Aires exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medtronic plc?
The stock symbol or ticker of Medtronic plc is MDT.BA.
Which industry does the Medtronic plc company belong to?
The Medtronic plc industry is Medical Devices.
How many shares does Medtronic plc have in circulation?
The max supply of Medtronic plc shares is 4.39B.
What is Medtronic plc Price to Earnings Ratio (PE Ratio)?
Medtronic plc PE Ratio is 3.85059670 now.
What was Medtronic plc earnings per share over the trailing 12 months (TTM)?
Medtronic plc EPS is 5453.7 ARS over the trailing 12 months.
Which sector does the Medtronic plc company belong to?
The Medtronic plc sector is Healthcare.